[Efficacy and tolerability of betamethasone dipropionate and iodochloroxyquinoline in the therapy of steroid-sensitive dermatoses].
D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007464:Clioquinol / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D008297:Male; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D004338:Drug Combinations; D006912:Hydroxyquinolines; D007464:Clioquinol; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone
Efficacia e tollerabilità di betametasone dipropionato e iodoclorossichinolina nella terapia delle dermatosi steroido-sensibili.